Journal
PROTEOMICS CLINICAL APPLICATIONS
Volume 4, Issue 3, Pages 250-270Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/prca.200900220
Keywords
Biobanking; Blood; Pre-analytical; Tissue
Funding
- Cancer Research UK
- MRC
- Department of Health
- Kidney Research UK
- Technology Strategy Board
Ask authors/readers for more resources
Biobanks with their collections of clinical samples and data are essential resources for the success of clinical proteomics in delivering and validating candidate biomarkers. Samples must be banked in a manner that allows maximum subsequent compatibility with analytical techniques and additionally many critical factors must be taken into account when establishing a biobank or selecting samples from a biobank. These include logistical, ethical, legal and security issues and, very importantly, steps to minimise any pre-analytical variability introduced through sample processing and handling (technical effects). The inherent variation present within the samples must also be taken into account. In this review, we examine the impact of these factors and issues to be faced when banking samples with a particular focus on sources of pre-analytical variation, which must be rigorously controlled and recorded. It is encouraging that several initiatives are now addressing such key issues and these are also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available